• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALK
Click for more information
0.75% 66.0¢

ALKANE RESOURCES LIMITED - Charts / Financials

Market Cap $398.2M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Gold

Alkane Resources Ltd is a gold production company with a multi-commodity exploration and... Alkane Resources Ltd is a gold production company with a multi-commodity exploration and development portfolio. Alkane’s projects are predominantly in the Central West region of NSW, but extend throughout Australia.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 16/04/2024 (20 minute delay) ?
Day
Open 69.5¢   Day High 69.5¢   Day Low 65.0¢
Daily Volume 1043575
Bids   Sellers
Number Price Volume   Number Price Volume
1 65.5¢ 9163   4 66.0¢ 19645

Directors & Senior Management

Mr. James J Carter Chief Financial Officer, Joint Company Secretary
Mr. Nicholas Paul Earner Managing Director, Executive Director
Mr. S. Parsons Executive General Manager - Operations
Mr. David Ian Chalmers Executive Director, Technical Director
Mr. Dennis William Wilkins Joint Company Secretary
Mr. Ian Jeffrey Gandel Non-Executive Independent Chairman of the Board
Mr. Anthony Dean Lethlean Senior Non-Executive Independent Director
Mr. Gavin Murray Smith Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
66.0¢ 		Change
-0.005(0.75%) 		Mkt cap ! $398.2M
Open High Low Value Volume
69.5¢ 69.5¢ 65.0¢ $693.6K 1.043M

Buyers (Bids)

No. Vol. Price($)
1 9163 65.5¢
 

Sellers (Offers)

Price($) Vol. No.
66.0¢ 19645 4
View Market Depth
Last trade - 16.10pm 16/04/2024 (20 minute delay) ?
Last
65.5¢ 		  Change
-0.005 ( 1.87 %)
Open High Low Volume
68.5¢ 68.5¢ 65.0¢ 177994
Last updated 15.59pm 16/04/2024 ?

Top Stories

Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs

Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Chariots of fire on pole to meet resurgent US lithium security focus. Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Market Update: Energy keeps light bright in a sea of red The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.